May 14, 2024 · Form 4 insider transaction
Korenberg Matthew E sold 520 shares of Ligand Pharmaceuticals Incorporated at $85.68 per share, a transaction worth $44.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $85.6250 to $85.7650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.